Article
The Ighmbp2D564N mouse model is the first SMARD1 model to demonstrate respiratory defects.
Human molecular genetics - 22 Apr 2022
Smith Caley E, Lorson Monique A, Ricardez Hernandez Sara M, Al Rawi Zayd, Mao Jiude, Marquez Jose, Villalón Eric, Keilholz Amy N, Smith Catherine L, Garro-Kacher Mona O, Morcos Toni, Davis Daniel J, Bryda Elizabeth C, Nichols Nicole L, Lorson Christian L
Abstract excerpt
Spinal muscular atrophy with respiratory distress type I (SMARD1) is a neurodegenerative disease defined by respiratory distress, muscle atrophy and sensory and autonomic nervous system defects. SMARD1 is a result of mutations within the IGHMBP2 gene. We have generated six Ighmbp2 mouse models based on patient-derived mutations that result in SMARD1 and/or Charcot-Marie Tooth Type 2 (CMT2S). Here we describe the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
